Inova Health Care Services

Inova Health Care Services, doing business as Inova Fairfax Hospital, is a non-profit healthcare organization and subsidiary of Inova Health System Foundation that provides specialized medical services, blood products, biorepository support, clinical research coordination, and patient care to the federal government as a prime contractor (63% of recent awards) and as a subcontractor (37%) on defense and health research initiatives. The organization competes full-and-open, without set-asides, reflecting its status as an established healthcare provider rather than a small business.

Inova operates from its headquarters in Fairfax, Virginia with performance locations at multiple campuses including Falls Church and Annandale, Virginia and federal clinical sites in Bethesda, Maryland and Alexandria, Virginia. The vendor's federal footprint centers on clinical research support, biospecimen collection and management, and hospital services delivery — concrete capabilities grounded in 163 recent awards with combined potential value of $49.8 million and combined obligated dollars of $185.7 million.

Customer concentration spreads across health research and defense agencies. The top five funding agencies account for 52% of awards: the National Heart Lung and Blood Institute leads by volume (30 awards, $6.5 million combined potential value), the Defense Health Agency (21 awards, $11.2 million), the Uniformed Services University of the Health Sciences (12 awards), the National Cancer Institute (11 awards, $40 thousand), and the Health Resources and Services Administration (10 awards). When ranked by potential value, the Department of State Bureau of Medical Services dominates (4 awards, $19.2 million), followed by the Defense Health Agency ($11.2 million), the National Highway Traffic Safety Administration (4 awards, $9.5 million), and the National Heart Lung and Blood Institute ($6.5 million). The two rankings diverge materially — State Department and NHTSA place fewer but substantially larger awards, while NHLBI places numerous smaller orders across biorepository and graft-protocol work.

Representative prime contract work includes a $2.7 million Defense Health Agency delivery order (awarded February 2025) for sterile processing services in Bethesda, Maryland running through February 2026; a $2.2 million National Highway Traffic Safety Administration indefinite delivery contract for Crash Injury Research and Engineering Network (CIREN) enrollment services and crash injury research through September 2028; a $1.9 million Department of State Bureau of Medical Services delivery order (March 2022 through September 2023) for medical instruments and supplies at Mosby, Virginia; a $763 thousand National Heart Lung and Blood Institute purchase order (September 2024) for multi-scale phenotyping of heart failure in diverse populations, terminated for convenience in March 2025; and a $639 thousand NHLBI purchase order (November 2022 through November 2026) for support services to the NHLBI/Inova Pulmonary Vascular Program at Falls Church. Inova also holds an NHTSA single-award indefinite delivery contract valued at $2.25 million through August 2027 for CIREN program support.

Grant work concentrates on maternal-fetal medicine, cardiac transplantation, cancer research, HIV prevention and support services, and neonatal health. Inova is the prime recipient of four federal grants: a National Institute of Child Health and Human Development award (August 2025 through July 2026) supporting the 18th Biennial Meeting of the Diabetes in Pregnancy Study Group of North America; an NICHD award (August 2023 through July 2024) for the 17th Biennial DPSG-NA Meeting; an NICHD award (August 2023 through July 2028) for optimal timing, route and dose of tranexamic acid in postpartum hemorrhage prevention; and a National Center for HIV/AIDS cooperative agreement (April 2022 through March 2027) for the Inova Juniper Program, a comprehensive high-impact HIV prevention initiative serving young men of color who have sex with men across Northern Virginia. Additionally, Inova is a sub-recipient on more than 40 federal research grants anchored by the National Institutes of Health (NHLBI, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Child Health and Human Development), the Defense Health Agency, the Department of Defense (through the Henry M. Jackson Foundation), the Department of State, and the Centers for Disease Control and Prevention. Sub-grant work spans cancer biobanking and proteogenomics (under the APOLLO program and Gynecologic Cancer Center of Excellence), cardiac research, HIV services, trauma and orthopedic outcomes, and neonatal sepsis biospecimen collection.

Inova's prime BPA and IDC work places task orders under the Defense Health Agency Blanket Purchase Agreement HT001417A0026 (7 task orders, $551 thousand), an NHLBI indefinite delivery contract for laboratory animal research support, and NHTSA's CIREN IDC. SCI-reported invoicing on federal service contracts above the $150,000 threshold totaled $983 thousand across three fiscal years (FY2023–FY2024), with roughly 2.2 FTEs delivering services in each year. Government-paid hourly rates on SCI-reportable work ran a median around $90.82/hr, with senior labor pricing through $121.29/hr, reflecting skilled clinical and research personnel. SCI coverage is a strict subset excluding the vendor's larger goods and biospecimen work that dominates its federal footprint.

Eight awards with combined potential value of $860 thousand reach ultimate completion within the next twenty-four months, representing recompete exposure primarily on NHLBI graft-protocol and biorepository work. As a subcontractor, Inova delivers clinical research support and biospecimen banking services to JS Technology, Inc. on the Study of Pregnancy and Neonatal Health (SPAN) recruitment and follow-up phase, and performs biomarker and rapid-response research support to prime contractors under NIH and Department of Defense funded initiatives. The vendor does not significantly employ downstream subcontractors on its own prime awards — SCI data show zero percent sub-hours share across prime contracts, indicating Inova builds and staffs its own delivery teams internally.